-
2
-
-
0021354536
-
Epidemiology of coronary heart disease: The Framingham study
-
Castelli WP. Epidemiology of coronary heart disease: the Framingham study. Am J Med. 1984;76:4-12.
-
(1984)
Am J Med
, vol.76
, pp. 4-12
-
-
Castelli, W.P.1
-
3
-
-
0024362676
-
Blood pressure and risk of fatal coronary heart disease
-
Stamler J, Neaton JD, Wentworth DN. Blood pressure and risk of fatal coronary heart disease. Hypertension. 1989;13(suppl I):I-2-I-12.
-
(1989)
Hypertension
, vol.13
, Issue.1 SUPPL.
-
-
Stamler, J.1
Neaton, J.D.2
Wentworth, D.N.3
-
4
-
-
0025347391
-
Blood pressure, stroke and coronary heart disease, II: Short-term reductions in blood pressure: Overview of randomized drug trials in their epidemiological context
-
MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke and coronary heart disease, II: short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet. 1990;335:827-838.
-
(1990)
Lancet
, vol.335
, pp. 827-838
-
-
MacMahon, S.1
Peto, R.2
Cutler, J.3
Collins, R.4
Sorlie, P.5
Neaton, J.6
Abbott, R.7
Godwin, J.8
Dyer, A.9
Stamler, J.10
-
5
-
-
0021863832
-
MRC trial of treatment of mild hypertension: Principal results
-
Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. BMJ. 1985;291:97-104.
-
(1985)
BMJ
, vol.291
, pp. 97-104
-
-
-
6
-
-
0023191508
-
Insulin resistance in essential hypertension
-
Ferrannini E, Buzzigoli G, Bonadonna R, Gionco MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilaqua S. Insulin resistance in essential hypertension. N Engl J Med. 1987;317:350-357.
-
(1987)
N Engl J Med
, vol.317
, pp. 350-357
-
-
Ferrannini, E.1
Buzzigoli, G.2
Bonadonna, R.3
Gionco, M.A.4
Oleggini, M.5
Graziadei, L.6
Pedrinelli, R.7
Brandi, L.8
Bevilaqua, S.9
-
7
-
-
0027195457
-
Decreased peripheral blood flow in the pathogenesis of the metabolic syndrome comprising hypertension, hyperlipidemia and hyperinsulinemia
-
Lind L, Lithell H. Decreased peripheral blood flow in the pathogenesis of the metabolic syndrome comprising hypertension, hyperlipidemia and hyperinsulinemia. Am Heart J. 1993(suppl);125:1494-1497.
-
(1993)
Am Heart J
, vol.125
, Issue.SUPPL.
, pp. 1494-1497
-
-
Lind, L.1
Lithell, H.2
-
8
-
-
0031449649
-
Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy
-
Lip GYH, Blann AD, Jones AF, Lin Lip P, Beevers DG. Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy. Am J Cardiol. 1997;80:1566-1571.
-
(1997)
Am J Cardiol
, vol.80
, pp. 1566-1571
-
-
Lip, G.Y.H.1
Blann, A.D.2
Jones, A.F.3
Lin Lip, P.4
Beevers, D.G.5
-
9
-
-
0027125530
-
The pathogenesis of coronary artery disease and the acute coronary syndromes
-
Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:242-250.
-
(1992)
N Engl J Med
, vol.326
, pp. 242-250
-
-
Fuster, V.1
Badimon, L.2
Badimon, J.J.3
Chesebro, J.H.4
-
11
-
-
0022485106
-
Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study
-
Meade TW, Brozovic M, Chakrabarti RR, Haines AP, Imeson JD, Mellows S, Miller GJ, North WRS, Stirling Y, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986;2:533-537.
-
(1986)
Lancet
, vol.2
, pp. 533-537
-
-
Meade, T.W.1
Brozovic, M.2
Chakrabarti, R.R.3
Haines, A.P.4
Imeson, J.D.5
Mellows, S.6
Miller, G.J.7
North, W.R.S.8
Stirling, Y.9
Thompson, S.G.10
-
12
-
-
0024996265
-
Diabetes, fibrinogen, and risk of cardiovascular disease: The Framingham experience
-
Kannel WB, D'Agostino RB, Wilson PWF, Belanger AJ Gagnon DR. Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience. Diabetes. 1990;120:672-676.
-
(1990)
Diabetes
, vol.120
, pp. 672-676
-
-
Kannel, W.B.1
D'Agostino, R.B.2
Wilson, P.W.F.3
Belanger, A.J.4
Gagnon, D.R.5
-
13
-
-
0027178119
-
Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: The Scottish Heart Health Study
-
Lee AJ, Lowe GDO, Woodward M, Tunstall-Pedoe H. Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study. Br Heart J. 1993;69:336-342.
-
(1993)
Br Heart J
, vol.69
, pp. 336-342
-
-
Lee, A.J.1
Lowe, G.D.O.2
Woodward, M.3
Tunstall-Pedoe, H.4
-
14
-
-
0028909230
-
Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
-
Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 1995;332:635-641.
-
(1995)
N Engl J Med
, vol.332
, pp. 635-641
-
-
Thompson, S.G.1
Kienast, J.2
Pyke, S.D.M.3
Haverkate, F.4
Van De Loo, J.C.W.5
-
15
-
-
0025948224
-
Von Willebrand factor in plasma: A novel risk factor for recurrent myocardial infarction and death
-
Jansson JH, Nilsson TK, Johnson O. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J. 1991;66:551-555.
-
(1991)
Br Heart J
, vol.66
, pp. 551-555
-
-
Jansson, J.H.1
Nilsson, T.K.2
Johnson, O.3
-
16
-
-
0019490723
-
Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects: Role of fibrinogen and concentration
-
Letcher RL, Chien S, Pickering TG, Sealey JE, Laragh JH. Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects: role of fibrinogen and concentration. Am J Med. 1981;70:1195-1202.
-
(1981)
Am J Med
, vol.70
, pp. 1195-1202
-
-
Letcher, R.L.1
Chien, S.2
Pickering, T.G.3
Sealey, J.E.4
Laragh, J.H.5
-
17
-
-
0027199192
-
Blood viscosity and peripheral vascular resistance in patients with untreated essential hypertension
-
Linde T, Sandhagen B, Hagg A, Morlin C, Wikstrom, Danielson BG. Blood viscosity and peripheral vascular resistance in patients with untreated essential hypertension. J Hypertens. 1993;11:731-736.
-
(1993)
J Hypertens
, vol.11
, pp. 731-736
-
-
Linde, T.1
Sandhagen, B.2
Hagg, A.3
Morlin, C.4
Wikstrom5
Danielson, B.G.6
-
18
-
-
0025756530
-
Association between plasma viscosity and blood pressure: Results from the MONICA-Project Augsburg
-
Koenig W, Sund M, Ernst E, Keil U, Rosenthal J, Hombach V. Association between plasma viscosity and blood pressure: results from the MONICA-Project Augsburg. Am J Hypertens. 1991;4:529-536.
-
(1991)
Am J Hypertens
, vol.4
, pp. 529-536
-
-
Koenig, W.1
Sund, M.2
Ernst, E.3
Keil, U.4
Rosenthal, J.5
Hombach, V.6
-
19
-
-
0026522735
-
Rheological determinants of blood pressure in a Scottish adult population
-
Smith WCS, Lowe GDO, Lee AJ, Tunstall-Pedoe H. Rheological determinants of blood pressure in a Scottish adult population. J Hypertens. 1992;10:467-472.
-
(1992)
J Hypertens
, vol.10
, pp. 467-472
-
-
Smith, W.C.S.1
Lowe, G.D.O.2
Lee, A.J.3
Tunstall-Pedoe, H.4
-
20
-
-
0028094888
-
Abnormalities of rheology and coagulation in hypertension
-
Lip GYH, Beevers DG. Abnormalities of rheology and coagulation in hypertension. J Hum Hypertens. 1994;8:693-702.
-
(1994)
J Hum Hypertens
, vol.8
, pp. 693-702
-
-
Lip, G.Y.H.1
Beevers, D.G.2
-
21
-
-
0024361816
-
Plasma plasminogen activator inhibitor-1 in angina pectoris: Influence of plasma insulin and acute-phase response
-
Juhan-Vague I, Alessi MC, Joly P, Thirion X, Vague P, Declerek PJ, Serradimigni A, Collen D. Plasma plasminogen activator inhibitor-1 in angina pectoris: influence of plasma insulin and acute-phase response. Arteriosclerosis. 1989;9:362-367.
-
(1989)
Arteriosclerosis
, vol.9
, pp. 362-367
-
-
Juhan-Vague, I.1
Alessi, M.C.2
Joly, P.3
Thirion, X.4
Vague, P.5
Declerek, P.J.6
Serradimigni, A.7
Collen, D.8
-
22
-
-
0023185776
-
Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction
-
Hamsten A, Walldius G, Szamosi A, Blomback M, de Faire U, Dahlen G, Wiman B. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet. 1987;2:3-9.
-
(1987)
Lancet
, vol.2
, pp. 3-9
-
-
Hamsten, A.1
Walldius, G.2
Szamosi, A.3
Blomback, M.4
De Faire, U.5
Dahlen, G.6
Wiman, B.7
-
23
-
-
0027441963
-
Fibrinolytic activity, clotting and long-term incidence of ischemic heart disease in the Northwick Park Heart Study
-
Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting and long-term incidence of ischemic heart disease in the Northwick Park Heart Study. Lancet. 1993;342:1076-1079.
-
(1993)
Lancet
, vol.342
, pp. 1076-1079
-
-
Meade, T.W.1
Ruddock, V.2
Stirling, Y.3
Chakrabarti, R.4
Miller, G.J.5
-
24
-
-
0027274074
-
Endogenous tissue-type plasminogen activator and risk of myocardial infarction
-
Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet. 1993;341:1165-1168.
-
(1993)
Lancet
, vol.341
, pp. 1165-1168
-
-
Ridker, P.M.1
Vaughan, D.E.2
Stampfer, M.J.3
Manson, J.E.4
Hennekens, C.H.5
-
25
-
-
0027360661
-
Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease: A 7-year follow-up
-
Jansen J-H, Olofsson B-O, Nilsson TK. Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease: a 7-year follow-up. Circulation. 1993;88: 2030-2034.
-
(1993)
Circulation
, vol.88
, pp. 2030-2034
-
-
Jansen, J.-H.1
Olofsson, B.-O.2
Nilsson, T.K.3
-
26
-
-
0031283158
-
The role of rheological and haemostatic factors in hypertension
-
Lee AJ. The role of rheological and haemostatic factors in hypertension. J Hum Hypertens. 1997;11:767-776.
-
(1997)
J Hum Hypertens
, vol.11
, pp. 767-776
-
-
Lee, A.J.1
-
27
-
-
0026064035
-
Decreased fibrinolytic activity and increased platelet function in hypertension: Possible influence of calcium antagonism
-
Gleerup G, Winther K. Decreased fibrinolytic activity and increased platelet function in hypertension: possible influence of calcium antagonism. Am J Hypertens. 1991;4:168s-171s.
-
(1991)
Am J Hypertens
, vol.4
-
-
Gleerup, G.1
Winther, K.2
-
29
-
-
0028595706
-
Fibrinolytic activity and platelet release reaction in essential hypertension
-
Keskin A, Tombuloglu M, Buyukkececi F. Fibrinolytic activity and platelet release reaction in essential hypertension. Jpn Heart J. 1994;35: 757-763.
-
(1994)
Jpn Heart J
, vol.35
, pp. 757-763
-
-
Keskin, A.1
Tombuloglu, M.2
Buyukkececi, F.3
-
30
-
-
0025234723
-
Elevated fibrinogen and plasminogen activator inhibitor in hypertension are related to metabolic risk factors for cardiovascular disease
-
Landin K, Tengborn L, Smith U. Elevated fibrinogen and plasminogen activator inhibitor in hypertension are related to metabolic risk factors for cardiovascular disease. J Intern Med. 1990;227:273-278.
-
(1990)
J Intern Med
, vol.227
, pp. 273-278
-
-
Landin, K.1
Tengborn, L.2
Smith, U.3
-
31
-
-
0025922062
-
Hypofibrinolysis in patients with hypertension and elevated cholesterol
-
Jansson JH, Johansson B, Boman K, Nilsson TK. Hypofibrinolysis in patients with hypertension and elevated cholesterol. J Intern Med. 1991; 229:309-316.
-
(1991)
J Intern Med
, vol.229
, pp. 309-316
-
-
Jansson, J.H.1
Johansson, B.2
Boman, K.3
Nilsson, T.K.4
-
32
-
-
0028355816
-
Fibrinogen and fibrinolytic variables in relation to anthropometry, lipids and blood pressure: The Northern Sweden MONICA Study
-
Eliasson M, Evrin PE, Lundblad D. Fibrinogen and fibrinolytic variables in relation to anthropometry, lipids and blood pressure: the Northern Sweden MONICA Study. J Clin Epidemiol. 1994;47:513-524.
-
(1994)
J Clin Epidemiol
, vol.47
, pp. 513-524
-
-
Eliasson, M.1
Evrin, P.E.2
Lundblad, D.3
-
33
-
-
0027256179
-
Von Willebrand factor and endothelial damage in essential hypertension
-
Blann AD, Naqvi T, Waite M, McCollum CN. von Willebrand factor and endothelial damage in essential hypertension. J Hum Hypertens. 1993;7: 107-111.
-
(1993)
J Hum Hypertens
, vol.7
, pp. 107-111
-
-
Blann, A.D.1
Naqvi, T.2
Waite, M.3
McCollum, C.N.4
-
34
-
-
0027417144
-
Coagulation factors and lipid composition of the blood in treated and untreated hypertensive patients
-
Donders SHJ, Lustermans FATh, Van Wersch JWJ. Coagulation factors and lipid composition of the blood in treated and untreated hypertensive patients. Scand J Clin Lab Invest. 1993;53:179-186.
-
(1993)
Scand J Clin Lab Invest
, vol.53
, pp. 179-186
-
-
Donders, S.H.J.1
Lustermans, F.A.Th.2
Van Wersch, J.W.J.3
-
35
-
-
0028784671
-
Enhanced levels of tissue-type plaminogen activator in borderline hypertension
-
Wall U, Jern C, Bergbrant A, Jem S. Enhanced levels of tissue-type plaminogen activator in borderline hypertension. Hypertension. 1995;26: 796-800.
-
(1995)
Hypertension
, vol.26
, pp. 796-800
-
-
Wall, U.1
Jern, C.2
Bergbrant, A.3
Jem, S.4
-
36
-
-
0029874352
-
The fibrinolytic system is not impaired in older men with hypertension
-
DeSouza CA, Dengel DR, Rogers MA, Cox K, Macko RF. The fibrinolytic system is not impaired in older men with hypertension. Hypertension. 1996;27:1053-1058.
-
(1996)
Hypertension
, vol.27
, pp. 1053-1058
-
-
DeSouza, C.A.1
Dengel, D.R.2
Rogers, M.A.3
Cox, K.4
Macko, R.F.5
-
37
-
-
0018612858
-
An investigation of coronary heart disease in families: The Framingham Offspring Study
-
Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families: the Framingham Offspring Study. Am J Epidemiol. 1979;110:281-290.
-
(1979)
Am J Epidemiol
, vol.110
, pp. 281-290
-
-
Kannel, W.B.1
Feinleib, M.2
McNamara, P.M.3
Garrison, R.J.4
Castelli, W.P.5
-
38
-
-
0003852222
-
-
Section 34. Bethesda, MD: National Heart, Lung, and Blood Institute. Publication No. (NIH) 87-2703
-
Kannel WB, Wolf PA, Garrison RJ, eds. The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease. Section 34. Bethesda, MD: National Heart, Lung, and Blood Institute; 1987. Publication No. (NIH) 87-2703.
-
(1987)
The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease
-
-
Kannel, W.B.1
Wolf, P.A.2
Garrison, R.J.3
-
39
-
-
0023840967
-
Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay
-
Declerck PJ, Alessi MC, Verstreken M, Kruithof EKO, Juhan-Vague I, Collen D. Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood. 1988;71:220-225.
-
(1988)
Blood
, vol.71
, pp. 220-225
-
-
Declerck, P.J.1
Alessi, M.C.2
Verstreken, M.3
Kruithof, E.K.O.4
Juhan-Vague, I.5
Collen, D.6
-
40
-
-
0022894665
-
Age dependence of tissue plasminogen activator concentrations in plasma, as studied by improved enzyme linked immunosorbent assay
-
Ranby M, Bergsdorf N, Nilsson T, Mellbring G, Winblad B, Bucht G. Age dependence of tissue plasminogen activator concentrations in plasma, as studied by improved enzyme linked immunosorbent assay. Clin Chem. 1986;32:2160-2165.
-
(1986)
Clin Chem
, vol.32
, pp. 2160-2165
-
-
Ranby, M.1
Bergsdorf, N.2
Nilsson, T.3
Mellbring, G.4
Winblad, B.5
Bucht, G.6
-
41
-
-
33745551242
-
Schnellmethode zur bestimmung des fibrinogens
-
Clauss A. Schnellmethode zur Bestimmung des fibrinogens. Acta Haematol. 1957;17:237-247.
-
(1957)
Acta Haematol
, vol.17
, pp. 237-247
-
-
Clauss, A.1
-
42
-
-
0025801764
-
Correlation of circulation von Willebrand factor levels with cardiovascular hemodynamics
-
Penny W, Weinstem M, Salzman EW, Ware JA. Correlation of circulation von Willebrand factor levels with cardiovascular hemodynamics. Circulation. 1991;83:1630-1636.
-
(1991)
Circulation
, vol.83
, pp. 1630-1636
-
-
Penny, W.1
Weinstem, M.2
Salzman, E.W.3
Ware, J.A.4
-
44
-
-
0001519073
-
The REG procedure
-
Cary, NC: SAS Institute Inc
-
SAS Institute Inc. The REG procedure. In: SAS/STAT User's Guide. Version 6. Vol 2. 4th ed. Cary, NC: SAS Institute Inc: 1989:1351-1456.
-
(1989)
SAS/STAT User's Guide. Version 6. 4th Ed.
, vol.2
, pp. 1351-1456
-
-
-
45
-
-
0030713021
-
-
The Sixth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure
-
Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-2446.
-
(1997)
Arch Intern Med
, vol.157
, pp. 2413-2446
-
-
-
46
-
-
0023484510
-
Comparison of plasminogen activator inhibitor activity and antigen in plasma samples
-
Urden G, Hamsten A, Wiman B. Comparison of plasminogen activator inhibitor activity and antigen in plasma samples. Clin Chim Acta. 1987; 169:189-196.
-
(1987)
Clin Chim Acta
, vol.169
, pp. 189-196
-
-
Urden, G.1
Hamsten, A.2
Wiman, B.3
-
47
-
-
0026656288
-
The variability of and associations between measures of blood coagulation, fibrinolysis and blood lipids
-
Marckmann P, Sandstrom B, Jepersen J. The variability of and associations between measures of blood coagulation, fibrinolysis and blood lipids. Atherosclerosis. 1992;96:235-244.
-
(1992)
Atherosclerosis
, vol.96
, pp. 235-244
-
-
Marckmann, P.1
Sandstrom, B.2
Jepersen, J.3
-
48
-
-
0023144444
-
Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: Correlation with age and serum triglyceride concentrations
-
Mehta J, Mehta P, Lawson D, Saldeen T. Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations. J Am Coll Cardiol. 1987;9: 263-268.
-
(1987)
J Am Coll Cardiol
, vol.9
, pp. 263-268
-
-
Mehta, J.1
Mehta, P.2
Lawson, D.3
Saldeen, T.4
-
49
-
-
0025251843
-
Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein
-
Stiko-Rahm A, Wiman B, Hamsten A, Nilsson J. Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein. Arteriosclerosis. 1990; 10:1067-1073.
-
(1990)
Arteriosclerosis
, vol.10
, pp. 1067-1073
-
-
Stiko-Rahm, A.1
Wiman, B.2
Hamsten, A.3
Nilsson, J.4
|